In Analysis | June 2022

Assessing ART Resistance and Clinical Outcomes of Children and Adolescents Transitioning to DTG based ARV Regimen in Côte d’Ivoire

Overview

Country:

Côte d’Ivoire

Subject Matter:

Pediatric and Adolescent Testing, Care, and Treatment

The primary goal of this ELMA -funded study is to estimate the proportion of ART resistance among treatment-experienced children and adolescents who transitioned to DTG-based regimens in Cote d’Ivoire. The study utilizes an observational prospective cohort of children and adolescents to assess ART resistance and explore the clinical, immunologic, and virologic outcomes at 3 and 6 months following transition to a DTG-based regimen.

Data Collection Period: 12/2021 – 10/2022